摘要
目的 观察宫瘤消联合米非司酮治疗子宫肌瘤的临床疗效.方法 选取80例子宫肌瘤患者,按收治顺序编号随机平均分为对照组和观察组,对照组只给予米非司酮治疗,观察组在对照组的基础上联合使用宫瘤消予以治疗,1个疗程后观察两组临床疗效.结果 对照组和治疗组的临床有效率分别为72.5％和92.5％,治疗组疗效显著高于对照组（x2=5.600,P＜0.01）.结论 宫瘤消联合米非司酮治疗子宫肌瘤安全可靠,具有显著的临床疗效.
Objective To explore the clinical curative effect of treating peptic ulcer by rabeprazole joint cla- rithromycin and amoxicillin. Methods 80 cases were divided randomly into control group and observation group. Pa- tients in the control group were given mifepristone, patients in the treatment group were given gongliuxiao on the base of the control group, after one course of treatment, the clinical curative effects of the two groups were evaluated. Results The clinical effective rate of the control group and observation group was 72.5 % and 92.5 %, respectively, the curative effect of treatment group was significantly better than that of control group（x2 =5. 600,P 〈 0. 01 ）. Conclusion The clinical curative effect of treating uterine fibroids by gongliuxiao combined with mifepristone is dis- tinct, safe and reliable.
出处
《中国基层医药》
CAS
2013年第19期2972-2973,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
平滑肌瘤
宫瘤消
缩宫素
Leiomyoma
Gongliuxiao
Mifepristone
